Low Hematocrit Is a Strong Predictor of Poor Prognosis in Lung Cancer Patients

Morbidity and mortality of lung cancer rank first in China and worldwide. Thus, noninvasive prognostic biomarkers are critical for clinicians to perform risk assessment in lung cancer patients prior to or during the course of treatment. In this study, we evaluated the prognostic value of preoperativ...

Full description

Saved in:
Bibliographic Details
Published in:Biomed Res Int
Main Authors: Zhang, Xin, Zhang, Fengmin, Qiao, Wenbo, Zhang, Xiansheng, Zhao, Zhefeng, Li, Mingqi
Format: Artigo
Language:Inglês
Published: Hindawi 2018
Subjects:
Clinical Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6207876/
https://ncbi.nlm.nih.gov/pubmed/30417013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/6804938
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items